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euroactive steroids are endogenous neuromod-
ulators that can be synthesized de novo in the brain as well
as in the adrenal glands,ovaries,and testes (for review see
ref 1).The biosynthetic pathway for these steroids is shown
in Figure 1.Among these compounds,the metabolites of
deoxycorticosterone (DOC) and progesterone,3α,21-dihy-
droxy-5α-pregnan-20-one (3α,5α-THDOC or allotetra-
hydrodeoxycorticosterone) and 3α-hydroxy-5α-pregnan-
20-one (3α,5α-THP or allopregnanolone) are the most
potent positive modulators of γ-aminobutyric acid type A
(GABAA) receptors.
2,3
Systemic administration of 3α,5α-THDOC and 3α,5α-
THP induces anxiolytic,anticonvulsant,and sedative-hyp-
notic effects,similar to those induced by other GABAA
463
Clinical research
N
Copyright © 2006 LLS SAS.  All rights reserved www.dialogues-cns.org
Hypothalamic-pituitary-adrenal axis 
modulation of GABAergic neuroactive
steroids influences ethanol sensitivity and
drinking behavior
A. Leslie Morrow, PhD; Patrizia Porcu, PhD; Kevin N. Boyd, BS;
Kathleen A. Grant, PhD
Keywords: hypothalamic-pituitary-adrenal axis, ethanol, neuroactive steroid,
rat, monkey, human 
Author affiliations: Departments of Psychiatry and Pharmacology, Bowles
Center for Alcohol Studies, University of North Carolina School of
Medicine, Chapel Hill, NC, USA (A. Leslie Morrow, Patrizia Porcu, Kevin N.
Boyd); Curriculum in Toxicology, University of North Carolina School of
Medicine, Chapel Hill, NC, USA (A. Leslie Morrow, Kevin N. Boyd);
Department of Behavioral Neurosciences & the Oregon National Primate
Research Center, Oregon Health & Science University, Portland, OR, USA
(Kathleen A. Grant) 
Address for correspondence: A. Leslie Morrow, Bowles Center for Alcohol
Studies, University of North Carolina School of Medicine, 3027 Thurston-Bowles
Building, CB #7178, Chapel Hill, NC 27599-7178, USA 
(email: morrow@med.unc.edu)
Activation of the hypothalamic-pituitary-adrenal (HPA) axis leads to elevations in -aminobutyric acid (GABA)-ergic
neuroactive steroids that enhance GABA neurotransmission and restore homeostasis following stress. This regulation
of the HPA axis maintains healthy brain function and protects against neuropsychiatric disease. Ethanol sensitivity is
influenced by elevations in neuroactive steroids that enhance the GABAergic effects of ethanol, and may prevent
excessive drinking in rodents and humans. Low ethanol sensitivity is associated with greater alcohol consumption and
increased risk of alcoholism. Indeed, ethanol-dependent rats show blunted neurosteroid responses to ethanol admin-
istration that may contribute to ethanol tolerance and the propensity to drink greater amounts of ethanol. The review
presents evidence to support the hypothesis that neurosteroids contribute to ethanol actions and prevent excessive
drinking, while the lack of neurosteroid responses to ethanol may underlie innate or chronic tolerance and increased
risk of excessive drinking. Neurosteroids may have therapeutic use in alcohol withdrawal or for relapse prevention.
© 2006, LLS SAS Dialogues Clin Neurosci. 2006;8:463-477.receptor positive modulators and ethanol (for review see
ref 4).Neuroactive steroids interact with GABAA recep-
tors via specific binding sites on α subunits
5 that allosteri-
cally modulate binding to GABA and benzodiazepine
recognition sites.
6 In addition,neuroactive steroids com-
pete for [
35S] t-butylbicyclophosphorothionate (TBPS)
binding sites.
6These steroids alter GABAA receptor func-
tion by enhancing GABA-mediated Cl
- conductance and
directly stimulating Cl
- conductance in voltage clamp stud-
ies and [
36Cl
-] flux studies.
2,3,7 Neuroactive steroids appear
to interact with multiple neurosteroid recognition sites,
8,9
and these sites may differentiate direct gating of Cl
- vs
allosteric modulation of GABA-mediated conductance
9
or represent different properties of recognition sites on
distinct GABAA receptor subtypes.
10,11 Studies of the struc-
tural requirements for neurosteroid activity at GABAA
receptors include 3α reduction and 5α/5β reduction of the
A ring,as well as hydroxylation of C21.
12The 5β-reduced
metabolites of DOC and progesterone, 3α,5β-THDOC
and 3α,5β-THP are equipotent modulators of GABAergic
transmission.
8,13,14 Humans synthesize these 5β-reduced
neuroactive steroids; moreover, the concentrations of
3α,5β-THP are physiologically relevant and comparable
to those of 3α,5α-THP in human plasma and cere-
brospinal fluid.
15,16 In addition,3α,5α- and 3α,5β-reduced
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Selected abbreviations and acronyms
3-HSD 3 hydroxysteroid dehydrogenase
3,5-THDOC 3,21-dihydroxy-5-pregnan-20-one
3,5-THP 3-hydroxy-5-pregnan-20-one
ACTH adrenocorticotropic hormone
CRF corticotropin-releasing factor
DOC deoxycorticosterone
GABA -aminobutyric acid
HPA hypothalamic-pituitary-adrenal
PMDD premenstrual dysphoric disorder
Figure 1. Biosynthetic pathway for neuroactive steroids. DHEA, dehydroepiandrosterone; DOC, deoxycorticosterone
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(AllotetrahydroDOC)cortisol have antagonist properties at both GABA and
neurosteroid recognition sites of GABAA receptors,and
these compounds are the most abundant metabolites of
cortisol in human urine.
17 However, to our knowledge,
there is no data in the literature on the presence of these
metabolites in human brain.
Stress increases plasma and brain levels of
GABAergic neuroactive steroids
The brain and plasma concentrations of GABA agonist-
like neuroactive steroids are increased by acute stress and
ethanol administration in rodents.
18-21 The increase in
3α,5α-THP reaches pharmacologically significant con-
centrations in brain between 50 and 100 nM that is suffi-
cient to enhance GABAA receptor activity and produce
behavioral effects.Similarly,both stress and acute ethanol
administration elevate levels of 3α,5α-THP in human
plasma,
22-25 although effects of ethanol in humans are con-
troversial.
26,27 In addition, corticotropin-releasing factor
(CRF) infusion increases 3α,5α-THP levels in human
plasma.
28The levels detected in human plasma are lower
than rodent plasma and brain.However,3α,5α-THP lev-
els in post-mortem human brain are similar to rat brain
and sufficient to have GABAergic activity.
29 Table I sum-
marizes the effects of acute stress on neuroactive steroid
levels in rodents,monkeys,and humans.
The increase in neuroactive steroid levels elicited by stress-
ful stimuli,including ethanol administration,appears to be
mediated by activation of the hypothalamic-pituitary-
adrenal (HPA) axis, since it is no longer apparent in
adrenalectomized animals.
18,30,31Adrenalectomized animals
exhibit no circulating concentrations of 3α,5α-THP and
3α,5α-THDOC,but brain levels are still detectable,
18 sug-
gesting that brain synthesis plays an important role in neu-
rosteroid actions.Indeed,brain synthesis of 3α,5α-THP
can be increased by ethanol in adrenalectomized imma-
ture animals allowed sufficient time for adaptation,
32 sug-
gesting that brain synthesis of neurosteroids may exhibit
plasticity in response to physiological challenges.
Neuroactive steroids and the HPA axis
The activation of the HPA axis in response to acute stress
increases the release of CRF from the hypothalamus,
which stimulates the release of adrenocorticotropic hor-
mone (ACTH) from the pituitary;this,in turn,stimulates
the adrenal cortex to release glucocorticoids,neuroactive
steroid precursors,and GABAergic neuroactive steroids.
Glucocorticoids,mainly cortisol in humans and nonhuman
primates,and corticosterone in rodents,provide negative
feedback on the hypothalamus and pituitary. Likewise,
GABAergic neuroactive steroids inhibit CRF production
and release,ACTH release,and subsequent corticosterone
levels in rodents.
33-35The ability of neuroactive steroids to
reduce HPA axis activation may play an important role in
returning the animal to homeostasis following stressful
events.This physiological coping response appears to be
critical for mental health,since it is dysregulated in vari-
ous mood disorders,including depression,post-traumatic
stress disorder, and premenstrual dysphoric disorder
(PMDD).
Neuroactive steroid concentrations are altered in various
pathophysiological conditions that involve dysfunction of
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Table I. Summary of the changes in neuroactive steroids and their precursors in rats, monkeys, and healthy human subjects induced by acute ethanol
administration or by acute stress or HPA stimulation. These effects are described and referenced in the text.    = increase;    = decrease; -- =
unchanged; na = not assayed; HPA axis: activation by naloxone, CRF, or ACTH; 3α,5α-THDOC, 3α,21-dihydroxy-5α-pregnan-20-one; 3α,5α-
THP, 3α-hydroxy-5α-pregnan-20-one; DOC, deoxycorticosterone; HPA, hypothalamic-pituitary-adrenal; CRF, corticotropin-releasing factor;
ACTH, adrenocorticotropic hormone
Pregnenolone Progesterone 3α,5α-THP DOC 3α,5α-THDOC
Rats
Acute ethanol
Acute stress NA
Monkeys
Acute ethanol -- NA NA -- NA
Acute stress/HPA axis / -- -- /  NA NA
Humans
Acute ethanol /  / -- /  NA NA
Acute stress/HPA axis NA
↓
↓
↓
↓
↓
↓
↓
↓
↓
↓
↓
↓
↓
↓
↓
↓
↓
↓
↓
↓↓
↓
↓the HPA axis.The HPA axis plays an important role in the
pathophysiology of depression: patients with major
depression have elevated cortisol levels,a consequence of
hypersecretion of CRF due to lowered feedback mecha-
nisms,
36 which also contributes to a blunted dexametha-
sone response.
37 Some neuroactive steroid concentrations
are decreased in patients with major depression as well as
in animal models of depression,
15,16,38,39 and administration
of antidepressant drugs increases these neuroactive
steroids in patients and in rodent brain and plasma.
40-44This
decrease in neuroactive steroids might play a role in the
hyperactivity of CRF,since neurosteroids negatively reg-
ulate CRF expression and release from the hypothalamus.
This increase might be mediated by the HPA axis via an
increased serotonin neurotransmission that stimulates the
release of CRF (for review see ref 45).While acute fluox-
etine administration increases brain levels of 3α,5α-THP,
chronic administration of fluoxetine decreases 3α,5α-THP
and 3α,5α-THDOC in rat brain and plasma,
43 probably as
a consequence of a reduced basal HPA axis activity
induced by antidepressant treatments.
36
Neuroactive steroids are also altered in PMDD,although
the literature is controversial,reporting either decrease,
no change,or increase in 3α,5α-THP plasma levels.
22,46-53
Differences in analytic methods, diagnostic criteria, or
presence of other comorbid psychiatric disorders might
account for these discrepancies. Furthermore, PMDD
patients had a blunted 3α,5α-THP response to stress
22 and
to HPA axis challenges.
53Women with a history of depres-
sion,regardless of PMDD symptoms,also had a blunted
3α,5α-THP response to stress.
54An altered neuroactive
steroid response to stress and acute ethanol administra-
tion has been shown in socially isolated animals,
38,55 and
this is accompanied by altered HPA axis responsiveness.
56
All this experimental evidence emphasizes the important
link between HPA axis function and neuroactive steroid
levels in the maintenance of homeostasis and healthy
brain function.
Neuroactive steroids have ethanol-like 
discriminative stimulus properties in rodents
and nonhuman primates
The discriminative stimulus paradigm can be used as an in
vivo assay of receptor-mediated activity, and may help
define the neurotransmitter systems that underlie the
behavioral effects of a given dose and class of drug.
57 In
addition,drug discrimination can be used as an assay of
subjective effects for cross-species comparisons.
58The rela-
tion between subjective effects of a drug and its reinforc-
ing effects is largely asymmetrical:reinforcing effects are
discriminable,but not all discriminable effects are rein-
forcing.
58 For example, ethanol can make a person feel
simultaneously drowsy,euphoric,and calm,but only some
of these subjective effects will be associated with increased
drinking of ethanol.
Neurosteroids such as 3α,5α-THP, 3α,5β-THP, 3β,5β -
THP, and 3α,5α-THDOC have been characterized in
drug discrimination procedures as similar to other
GABAA receptor positive modulators,including benzo-
diazepines, barbiturates, and ethanol in rats and mice
(reviewed in ref 59).Further,neurosteroids that are neg-
ative modulators of GABAA receptor function,such as
pregnenolone sulfate and dehydroepiandrosterone sul-
fate, do not substitute for the discriminative stimulus
effects of ethanol.
60 However,in male rats,the basis for
the 3α,5β-THP discrimination also appears to be com-
posed of N-methyl-D-aspartate (NMDA) receptor antag-
onism and serotonin-3 (5-HT3) receptor agonist activity,
61
an effect not found in mice.
59 These results suggest a
species difference in the neurotransmitter systems under-
lying the 3α,5β-THP stimulus cues.
In the macaque monkey,3α,5α-THP produces a discrim-
inative stimulus effect that is similar to that of ethanol,and
sensitivity to these effects is dependent upon the phase of
the menstrual cycle,with higher circulating progesterone
in the menstrual cycle producing increased sensitivity to
ethanol.
62 Furthermore, in male and female monkeys,
3α,5α-THP can produce stimulus effects similar to both a
relatively low (1.0 g/kg) and higher (2.0 g/kg) dose of
ethanol.
63The common element in all three species tested
(mice,rats,and monkeys) appears to be positive GABAA
receptor modulation.
The neurosteroid 3α,5β-THP substitution for ethanol
shows wide individual differences in rats,mice,and mon-
keys.
59,60,62This is an unusual finding,because there is exten-
sive training involved in establishing the discrimination,
and such overtraining dampens variance across individu-
als.It has been speculated that the source of such individ-
ual variance in sensitivity to neurosteroids is due to the
additive effect of experimenter-administered neuros-
teroids with circulating levels in neurosteroids that differ
due to individual variations of HPA axis function.
60
Monkeys also show a wide individual variation in the
amount of ethanol they will self-administer,from an aver-
age of 1 to 2 drinks/day to an average of over 12
Clinical research
466drinks/day.The relationship between sensitivity to ethanol-
like effects of neurosteroids and propensity to self-admin-
ister ethanol has not been directly tested.However,the
suggestion from data showing lower sensitivity to the dis-
criminative stimulus effects of ethanol in the follicular
phase of the menstrual cycle (when progesterone and
DOC levels are low) and increased alcohol consumption
in women during the follicular phase is intriguing.
64 In
addition, it has been documented in women who drink
heavily and monkeys who self-administer high daily doses
of ethanol that their menstrual cycles are disrupted and
progesterone levels are very low.
65,66 It will be of interest to
first determine sensitivity to the discriminative stimulus
effects of ethanol and then allow monkeys to self-admin-
ister ethanol to more directly correlate aspects of discrim-
inative stimuli (subjective effects) with risk for heavy
drinking.
Neuroactive steroids mediate specific 
ethanol actions following acute 
administration in rodents
Systemic administration of moderate doses (1 to 2.5 g/kg)
of ethanol increases both plasma and brain levels of
3α,5α-THP and 3α,5α-THDOC.
19,21,31,67,68 Ethanol-induced
elevations in neuroactive steroids reach physiologically
relevant concentrations that are capable of enhancing
GABAergic transmission.The effect of ethanol on neu-
roactive steroid levels is dose- and time-dependent,and
correlates with the time course of some, but not all,
effects of ethanol.For example,the motor incoordinat-
ing effects of ethanol appear prior to elevations in neu-
roactive steroids,
69 whereas the anticonvulsant effects of
ethanol appear in congruence with elevations of these
steroids.
68A large body of evidence from multiple labo-
ratories suggests that ethanol-induced elevations of
GABAergic neuroactive steroids contribute to many
behavioral effects of ethanol in rodents. Neuroactive
steroids have been shown to modulate ethanol’s anti-
convulsant effects,
68 sedation,
30 impairment of spatial
memory,
4,70 anxiolytic-like,
71 and antidepressant-like
72
actions.Each of these behavioral responses is prevented
by pretreatment with the biosynthesis inhibitor finas-
teride and/or by prior adrenalectomy.The hypnotic effect
of ethanol is partially blocked by adrenalectomy.
Importantly,administration of the immediate precursor
of 3α,5α-THP restores effects of ethanol in adrenalec-
tomized animals, showing that brain synthesis of neu-
roactive steroids modulates effects of ethanol.
30 However,
neuroactive steroids do not appear to influence the
motor incoordinating effects of ethanol, since neither
finasteride administration or adrenalectomy diminish
these actions.
69Taken together,these studies suggest that
elevations in neuroactive steroids influence many of the
GABAergic effects of ethanol in vivo and the effects of
neuroactive steroids may determine sensitivity to many
behavioral effects of ethanol.
Neuroactive steroid precursors are increased
by acute ethanol administration in rodents
While several studies have demonstrated that acute
ethanol challenges can result in significant increases in
neuroactive steroids in plasma and brain,fewer studies
have examined in detail the importance of ethanol’s
effect on their precursors.As early as the 1940s, it was
found that DOC acetate and progesterone induced anes-
thetic effects in rats
73 and both DOC and progesterone
had antiseizure effects,
74 probably due to their 3α-
reduced metabolites.
75,76 DOC, the precursor of 3α,5α-
THDOC,and progesterone,the precursor of 3α,5α-THP,
can readily cross the blood-brain barrier and distribute
throughout the brain.These precursors of GABAergic
neuroactive steroids are synthesized in the adrenals,
beginning with cholesterol’s metabolism to pregnenolone
(Figure 1).While small amounts of these steroids may be
formed de novo in the brain,ethanol-induced increases
in neuroactive steroids are predominantly formed from
adrenal precursors.
77 Plasma and brain concentrations of
pregnenolone and progesterone are increased more
rapidly than 3α,5α-THP after acute ethanol administra-
tion.
31,78 Other studies have also shown increases in both
plasma and brain DOC after acute ethanol administra-
tion.DOC levels were increased in cerebral cortex,cere-
bellum,hippocampus,hypothalamus,and olfactory bulb
and tubercle,ranging from 28-fold increases in the cere-
bellum to 38-fold increases in the hypothalamus.
79A sig-
nificant increase in DOC levels across many brain
regions has also been reported by Kraulis et al following
intravenous injections of [1,2-
3H]-DOC.
80A strong cor-
relation exists between plasma and brain levels of DOC.
The temporal and regional associations found in these
studies suggest that the steroids originate in the adrenals
and are transported to the brain.Upon entering the brain
the steroids are metabolized by 5α-reductase and 3α-
dehydrogenase enzymes.These enzymes display brain
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467region and cell specific expression
81 that may be respon-
sible for the regional distribution of steroid levels fol-
lowing acute ethanol administration.Furthermore,DOC
levels measured in the Khisti et al study are comparable
to 3α,5α-THDOC levels measured in plasma and brain,
21
suggesting that DOC formed after acute ethanol admin-
istration may be largely converted to the GABAergic
neurosteroid 3α,5α-THDOC.Studies of ethanol’s effects
on neurosteroid precursors are important not only to
determine the sources and synthesis of potent metabo-
lites,but also to establish their role in physiological func-
tions.
Effects of neuroactive steroids on drinking
behavior in rodents
The GABAergic system is important in regulating
ethanol consumption,and neurosteroids can also alter
drinking behavior through their actions on GABAA
receptors. 3α,5α-THP dose-dependently increased
ethanol self-administration in nondependent ethanol-
preferring P rats,while decreasing ethanol administration
in ethanol-dependent P rats.
4 This suggests a complex
relationship whereby neurosteroids may promote drink-
ing in nondependent animals consuming small amounts
of ethanol,while protecting against excessive drinking in
dependent animals.This possibility is supported by data
in male C57BL/6J mice where 3α,5α-THP dose-depen-
dently modulated ethanol intake in a 2-hour session,with
low doses (3.2 mg/kg) increasing ethanol consumption
and high doses (24 mg/kg) decreasing ethanol consump-
tion.
82 In addition, at doses of 10 and 17 mg/kg, 3α,5α-
THP has been shown to have rewarding properties in
mice.
83 However,other studies in nondependent rats have
shown that pretreatment with a 3 mg/kg dose of 3α,5α-
THP,but not a 1- or 10-mg/kg dose,increases oral self-
administration of ethanol.
84 This result suggests that
3α,5α-THP dose-dependently mediates some of the rein-
forcing effects of ethanol,and its concentration in brain
may have an important influence on drinking behavior.
Indeed, Sardinian alcohol-preferring rats have larger
3α,5α-THP and 3α,5α-THDOC elevations after ethanol
administration than their non-alcohol-preferring coun-
terparts.
21 Other studies have shown that increased
ethanol intake after 3α,5α-THP administration is selec-
tive for ethanol-reinforced responding, and cannot be
attributed to palatability or increased motor activity dur-
ing the experimental sessions.
85 Furthermore,the ethanol
enhanced responses following 3α,5α-THP administration
produces the opposite effect of other GABAA receptor
agonists,such as muscimol and barbiturates,
85 suggesting
a unique role for GABAA receptor neurosteroid binding
sites in regulating ethanol consumption. Interestingly,
ethanol-dependent rats develop tolerance to ethanol-
induced increases in neurosteroid levels,
4,79 which may
influence the excessive drinking that is observed in
ethanol-dependent rats.
86Together,these data suggest a
strong relationship between neurosteroid levels and
ethanol consumption that may involve both genetic and
environmental factors.
Mechanisms of ethanol-induced elevations of
neuroactive steroids in plasma and brain
Ethanol-induced elevations in neuroactive steroids
appear to involve activation of the HPA axis to increase
circulating levels of neuroactive steroids and their pre-
cursors,as well as direct effects of ethanol on brain syn-
thesis.Adrenalectomy completely blocks the effects of
ethanol on cerebral cortical 3α,5α-THP concentrations;
however,the effect of ethanol on cerebral cortical levels
of 3α,5α-THP can be restored by administration of its
precursor,5α-dihydroprogesterone (5α-DHP),to adrena-
lectomized rats.
30 Since the steroid biosynthetic enzymes
are present across brain,
87 it is likely that ethanol-induced
increases in brain levels of neuroactive steroids involve
brain synthesis that may contribute to effects of ethanol.
The first step in steroid synthesis is the translocation of
cholesterol from the outer mitochondrial membrane to
the inner mitochondrial membrane,where P450scc con-
verts it to pregnenolone. This step is mediated by
steroidogenic acute regulatory protein (StAR) and/or the
peripheral benzodiazepine receptor. Ethanol rapidly
increases the synthesis and translocation of StAR pro-
tein from the cytosol to the mitochondria in the adrenal
gland.
30 Hence,it is likely that increases in GABAergic
neuroactive steroids in adrenals are secondary to
ethanol-induced increases in all steroid synthesis initiated
by StAR activity.
To determine if ethanol could alter other steroidogenic
enzyme activity in rat brain and adrenal minces,Morrow
and colleagues investigated the effects of ethanol on 5α-
reductase and 3α-hydroxysteroid dehydrogenase (3α-
HSD) enzyme activity (unpublished data).Ethanol (10 to
100 mM) did not alter 5α-reductase activity,measured by
the conversion of [
14C]progesterone to [
14C]5α-DHP in tis-
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sue minces.In contrast,ethanol (30 to 100 mM) increased
the conversion of [
14C]5α-DHP to [
14C]3α,5α-THP by a
maximum of 30 ± 3.6% in the olfactory bulb and tubercle,
but had no effect in the adrenal gland. Ethanol did not
alter nicotinamide adenine dinucleotide phosphate
(NADPH) effects on enzyme activity. Fluoxetine was
tested as a positive control since previous studies showed
that fluoxetine decreased the Km of a recombinant 3α-
HSD enzyme.
88 Fluoxetine increased the activity of 3α-
HSD enzyme in the olfactory bulb and tubercle and
adrenal gland and this effect was blocked by the 3α-HSD
inhibitor indomethacin.Since the 3α-HSD enzyme pos-
sesses bidirectional activity,the effect of ethanol on the
oxidative activity of 3α-HSD was determined.Ethanol did
not alter the conversion of [
3H]3α,5α-THP to [
3H]5α-DHP
in rat olfactory bulb and tubercle or adrenal gland.An
increase in the reductive activity of the 3α-HSD with no
change in the oxidative direction would cause a greater
conversion of 5α-DHP to 3α,5α-THP.This effect could
contribute to ethanol-induced increases in brain 3α,5α-
THP levels.Indeed,the increased reductive activity of 3α-
HSD would be predicted to increase brain levels of both
3α,5α-THP and other 3α,5α-reduced neuroactive steroids
such as 3α,5α-THDOC.
Suppression of neuroactive steroid responses
following chronic ethanol exposure in rats
It is well known that chronic stress results in adaptation
of the HPA axis,leading to decreased levels of corticos-
terone in rats.
89 Repeated exposure to alcohol also blunts
the response of the HPA axis to a second ethanol chal-
lenge.
90This blunting of the HPA axis is associated with
reduction in CRF and ACTH elevations following
ethanol challenge.
91 In line with these observations,
chronic ethanol consumption in rats results in blunted
elevation of cerebral cortical 3α,5α-THP
4 and plasma
and brain DOC levels following acute ethanol chal-
lenge,
79 compared with pair-fed control rats.These find-
ings suggest that there is tolerance to ethanol-induced
increases in neuroactive steroid levels.Since decreases in
brain neurosteroid levels were concomitant with
decreases in plasma neurosteroid levels,it is likely that
the observed decreases in 3α,5α-THP and DOC levels
were dependent on blunted HPA axis activity. Thus,
adaptations of the HPA axis may contribute to tolerance
to effects of ethanol that are mediated by the
GABAergic neuroactive steroids.
Chronic ethanol administration to rodents and humans
produces tolerance to ethanol and cross-tolerance to
benzodiazepines and barbiturates.In contrast,ethanol-
dependent rats are sensitized to the anticonvulsant
effects of both 3α,5α-THP and 3α,5α-THDOC.
92-94These
studies also show that GABAA receptor sensitivity to
3α,5α-THP and 3α,5α-THDOC is enhanced in ethanol-
dependent rats, likely due to the reduction of ethanol-
induced levels in these animals described above.Since
ethanol-dependent rats are sensitized to anticonvulsant
actions of neuroactive steroids,this class of compounds
may be therapeutic during ethanol withdrawal.Indeed,
neurosteroid therapy may have advantages over benzo-
diazepine therapy since benzodiazepines exhibit cross-
tolerance with ethanol. Further studies are needed to
explore this possibility.
Effects of ethanol on neuroactive 
steroids in humans
The potential role of neuroactive steroids in alcohol
action in humans is relatively unexplored and inconsis-
tent.Recent human studies show that male and female
adolescents seen in the emergency room for alcohol
intoxication had elevated plasma levels of the neuroac-
tive steroid 3α,5α-THP.
24,25 Furthermore,various subjec-
tive effects of ethanol during the rising phase of the
blood alcohol curve are diminished by prior administra-
tion of the neurosteroid biosynthesis inhibitor finas-
teride.
95 Finasteride reduces the formation of both 3α,5α-
THP and 3α,5α-THDOC by inhibiting the reduction of
progesterone and DOC to intermediate precursors.
Indeed, finasteride pretreatment blocked subjective
effects of alcohol using three different scales to measure
the activating, sedating, anesthetic, and peripheral
dynamic aspects of alcohol actions.The ability of finas-
teride to reduce the subjective effects of alcohol was not
observed in individuals carrying the GABAA α2 subunit
polymorphism associated with alcoholism, suggesting
that individuals carrying this polymorphism have reduced
sensitivity to both alcohol and finasteride.
95 Other stud-
ies show that 3α,5α-THP levels are decreased during the
peak of alcohol withdrawal and return to normal levels
upon recovery.
96,97 Likewise,abstinent alcoholics exhibit
diminished progesterone levels as well as a lowered ratio
of progesterone to pregnenolone.
98 In contrast,labora-
tory administration of low or moderate doses of ethanol
appears to have no effect on plasma 3α,5α-THP levels
26or to decrease 3α,5α-THP levels.
27,99 The basis of these
conflicting results is unknown,but may involve pharma-
cologically different ethanol doses, different analytic
methods to measure neurosteroids,or environmental fac-
tors that influence neurosteroid synthesis in humans.
Alternatively,different neuroactive steroids may be ele-
vated in humans vs rodents,or the effects of ethanol on
neuroactive steroid levels in humans may be restricted to
brain.Table I summarizes the different effects of ethanol
on neuroactive steroid levels in rodents, monkeys, and
humans.
Humans,but not rodents,synthesize multiple 5β-reduced
neuroactive steroids including 3α,5β-THP and 3α,5β-
THDOC. 3α,5β-THP levels are comparable to those of
3α,5α-THP in human plasma and cerebrospinal fluid.
15,16
These neuroactive steroids also modulate GABAergic
transmission,
8,13,14 but have not been measured in humans
after ethanol administration. Additionally, the primary
stress steroids in humans are cortisol and 11-deoxycorti-
sol,while progesterone and corticosterone are the primary
stress steroids in rodents.3α,5β-reduced cortisol is a neg-
ative modulator of GABAA receptors,
17 and could con-
tribute to the subjective effects of ethanol in humans.Thus,
the combined effects of 3α,5α- and 3α,5β-reduced neu-
roactive steroids may contribute to the effects of ethanol
in humans and nonhuman primates.These steroids have
never been measured following ethanol, stress, or HPA
axis activation in humans or nonhuman primates.
Comprehensive studies of neuroactive steroid levels in
humans are needed. While 3α,5α-THP and 3α,5α-
THDOC are the primary neuroactive steroids in rodents,
other neuroactive steroids may be more relevant in
humans. For example, plasma progesterone of adrenal
origin is present at much higher levels in rodents than
humans,suggesting an explanation for higher levels of
plasma 3α,5α-THP in rodents vs humans. Other
GABAergic 3α,5α- and 3α,5β-reduced neuroactive
steroids, derived from DOC, dehydroepiandrosterone
(DHEA),and testosterone,are known GABAergic mod-
ulators
100-102 that may be elevated by HPA axis activation
in humans. Unfortunately, simple inexpensive analytic
methods to measure these steroids are not available.The
ability of finasteride to block the subjective effects of
ethanol in humans may be due to its ability to prevent
the formation of any or all of these neuroactive steroids.
Indeed,the combined effects of all steroids regulated by
acute or chronic ethanol exposure may contribute to its
actions in all species.
Effects of ethanol on neuroactive steroid 
precursors in nonhuman primates 
and humans
We have recently shown that acute ethanol challenges in
cynomolgus monkeys do not change plasma pregnenolone
and DOC levels.Two doses of ethanol,1.0 and 1.5 g/kg,
were tested via intragastric administration,and neither was
able to increase neuroactive steroid precursors or circu-
lating cortisol levels despite an average blood ethanol level
of 147 mg/dL.
103,104 In contrast,acute ethanol administra-
tion increases pregnenolone,progesterone,DOC,and their
neuroactive metabolites in rat brain and plasma,
4,31,79,105 and
this increase is also prevented by adrenalectomy/orchiec-
tomy, consistent with ethanol activation of the HPA
axis.
31,105These results suggest that higher doses of ethanol
might be necessary to stimulate the HPA axis and thus
increase pregnenolone and DOC levels in nonhuman pri-
mates.Indeed,Williams and collaborators
106 have shown
that intravenous administration of ethanol up to 1.9 g/kg
failed to increase plasma ACTH levels in rhesus monkeys.
Other studies using 2.0 g/kg ethanol have reported
increased cortisol levels in monkeys under conditions
where monkeys were restrained on a flat surface while
receiving ethanol,which may contribute to HPA axis acti-
vation.
107 The possibility that pregnenolone, DOC, and
their neuroactive metabolites might be differentially reg-
ulated in nonhuman primates compared with rodents can-
not be ruled out;future studies will be necessary to further
address this question.
The effects of ethanol on neuroactive steroid precursors
in humans are inconsistent to date.Laboratory adminis-
tration of moderate doses of ethanol (0.7 to 0.8 g/kg) has
recently been reported to increase pregnenolone and
DHEA levels and to decrease progesterone levels in
healthy human subjects.
27 In contrast, Holdstock et al
26
reported that ethanol administration to healthy volunteers
increased progesterone levels in women during the luteal
phase,but had no effect during the follicular phase or in
men.Low alcohol consumption in premenopausal women
was associated with increased estradiol,androstenedione,
and testosterone levels throughout the menstrual cycle,
while progesterone levels were increased only in the luteal
phase.
108 Moreover,abstinent alcoholic women had dimin-
ished progesterone levels and a lower progesterone to
pregnenolone ratio during the luteal phase.
98 In contrast,
others reported that chronic male alcoholics had higher
basal progesterone compared with healthy controls.
109
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These variable data suggest that genetic and/or environ-
mental factors may influence effects of ethanol on steroid
precursors.
HPA axis modulation in 
alcohol-dependent humans
Among the neuropsychiatric disorders that show alter-
ations in HPA axis responsiveness is alcoholism.ACTH
and cortisol secretion is increased during ethanol intoxi-
cation and acute alcohol withdrawal.
110-117 In contrast,an
attenuated responsiveness of the HPA axis has been found
in both drinking and abstinent alcohol-dependent patients.
Alcohol-dependent patients have low cortisol and 11-
deoxycortisol basal levels,show a greater suppression in
cortisol and ACTH concentrations following dexametha-
sone test,and have a reduced cortisol response to exoge-
nous ACTH administered after dexamethasone.
118
Moreover, they have attenuated ACTH and cortisol
responses after pituitary stimulation by ovine or human
CRF
119-122 and an altered ACTH response to naloxone.
123
An altered cortisol and ACTH response to ovine CRF and
naloxone have also been found in sons of alcoholics.
124-126
These data are consistent with the idea that HPA axis dys-
regulation may contribute to altered neurosteroid
responses in human alcoholism,though studies showing
this consequence of alcoholism are not available to date.
HPA axis modulation of DOC and 
pregnenolone in cynomolgus monkeys
While stimulation of the HPA axis by acute stress or
ethanol administration plays a pivotal role in increasing
GABAergic neuroactive steroids and their precursors in
rodent brain and plasma,few data are available for non-
human primates. We have recently demonstrated that
plasma DOC and pregnenolone levels in ethanol-naïve
cynomolgus monkeys are differentially regulated by var-
ious challenges to the HPA axis.
103,104 Plasma DOC levels
are sensitive to hypothalamic and pituitary activation of
the axis and to negative feedback mechanisms assessed by
the dexamethasone test.Thus,administration of naloxone
at the doses of 125 and 375 µg/kg increased plasma DOC
levels up to 86% and 97%,respectively.This is consistent
with data showing an activation of the HPA axis and
increased cortisol and ACTH levels in humans and non-
human primates.
125,127,128 CRF (1 µg/kg) increased plasma
DOC levels up to 111%,and this increase was positively
correlated with the increase in cortisol levels in the same
subject,dexamethasone (130 µg/kg) decreased DOC lev-
els by 42%,in agreement with a suppression of HPA axis
activity.In contrast,administration of ACTH (10 ng/kg) 4-
6 hours after 0.5 mg/kg dexamethasone had no effect on
plasma DOC levels,suggesting that DOC synthesis is inde-
pendent of ACTH stimulation of the adrenals.
Furthermore,changes in DOC levels were correlated with
changes in cortisol levels only for some of these challenges,
suggesting that other neuroendocrine factors could regu-
late DOC synthesis in nonhuman primates.
103
Pregnenolone levels in the same cynomolgus monkey sub-
jects were differentially regulated from DOC.Naloxone
administration (125 and 375 µg/kg) increased plasma preg-
nenolone up to 222 and 216%,respectively.In contrast,
CRF (1 µg/kg) and dexamethasone (130 µg/kg) had no
effect on pregnenolone levels,while ACTH (10 ng/kg),4
to 6 hours after 0.5 mg/kg dexamethasone, decreased
plasma pregnenolone levels by 43%. CRF and ACTH
administration decreased the ratio of plasma preg-
nenolone:DOC,suggesting increased metabolism of preg-
nenolone into DOC or other steroids.
104Thus,circulating
pregnenolone levels are subject to complex regulation
involving factors other than direct HPA axis modulation.
Naloxone could increase pregnenolone levels through
mechanisms independent of HPA axis activation, given
that exogenous CRF and ACTH had no effect on preg-
nenolone levels.Opioid receptors are present in periph-
eral tissue including the adrenals,
129 and a direct action of
naloxone on these receptors cannot be ruled out.
Opioidergic neurons regulate gonadotropin-releasing hor-
mone (GnRH) secretion,
130 and it is possible that the
increase in plasma pregnenolone levels induced by nalox-
one is due to increased gonadal steroidogenesis via opioid
inhibition of GnRH.Furthermore,naloxone could have a
direct action on the enzymes involved in steroid biosyn-
thesis.Further studies are needed to investigate these pos-
sibilities.
Are neuroactive steroid responses to HPA axis
stimulation linked to alcohol drinking?
Neuroactive steroid responses to HPA axis challenges in
ethanol-naïve animals may predict future alcohol con-
sumption.Studies have so far focused on nonhuman pri-
mates.Dexamethasone suppresses DOC levels in monkey
plasma and the degree of dexamethasone suppression
measured in ethanol-naïve monkeys was predictive of sub-sequent alcohol drinking in these monkeys.That is, the
highest alcohol drinking was found in the monkeys that
showed the lowest suppression of DOC levels in response
to dexamethasone.
103 In this study,the monkeys with the
lowest response to dexamethasone also developed a pat-
tern of chronic binge drinking,drinking the equivalent of
16 or more drinks in 22 h in approximately 20% of their
drinking sessions (Grant et al, submitted). This binge
drinking pattern of high quantity of alcohol intake in short
time periods persisted throughout 1 year of ethanol self
administration (Grant et al,unpublished).In contrast,no
other DOC responses to HPA axis stimulation in ethanol-
naïve monkeys were predictive of subsequent voluntary
drinking or binge drinking.The effect of dexamethasone
on plasma DOC levels in monkeys appears to be a trait
marker of risk for high alcohol consumption.This trait
marker also correlated with alcohol intakes in a small
group (n=4) of rhesus monkeys (unpublished data col-
lected in collaboration with David P.Friedman at Wake
Forest University).These findings need to be replicated in
other primate studies of ethanol self-administration,
including cohorts of humans that have not yet started
drinking.This adaptation in precursor responses suggests
there will also be adaptations in GABAergic neuroactive
steroids derived from DOC.
Potential role of neuroactive steroids in
ethanol sensitivity and risk for alcoholism: 
a hypothesis
While the physiological significance is unknown,dysregu-
lation of the HPA axis is associated with ethanol depen-
dence in humans.
118,122 HPA axis suppression in alcohol
dependence results in diminished elevations of
GABAergic neuroactive steroids in rodents as described
above.Diminished elevations of GABAergic neuroactive
steroids following ethanol exposure would result in
reduced sensitivity to the anxiolytic,sedative,anticonvul-
sant, cognition-impairing, and discriminative stimulus
properties of ethanol. Reduced sensitivity to ethanol is
associated with greater risk for the development of alco-
holism in individuals with alcoholism in their family.
131,132
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Figure 2. Schematic representation of the hypothetical role of neuroactive steroids in ethanol sensitivity and risk for alcoholism. GABA, γ-aminobu-
tyric acid
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Hypothetical role of neuroactive steroids in alcoholism
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Moreover,individuals with the GABAA receptor α2 sub-
unit polymorphism that is associated with alcohol depen-
dence exhibit substantially reduced sensitivity to the sub-
jective effects of ethanol compared with individuals that
lack this polymorphism.
95 Likewise,rats and mice with low
sensitivity to various behavioral effects of alcohol tend to
self-administer greater amounts of ethanol in laboratory
settings.The BXD recombinant inbred strains of mice,
PKCγand PKCεknockout mice,alcohol-preferring P rats,
and high-alcohol-drinking (HAD) rats are but a few
examples.Taken together,these observations suggest that
ethanol-induced elevations of GABAergic neuroactive
steroids in brain may underlie important aspects of
ethanol sensitivity that may serve to prevent excessive
alcohol consumption (Figure 2). The loss of these
responses may promote excessive alcohol consumption to
achieve the desired effects of ethanol.A deficiency in neu-
rosteroid responses to ethanol intake could result from
suppression of the HPA axis or other genetic/environ-
mental factors that inhibit neurosteroid synthesis in brain.
Hence,the lack of neurosteroid elevations in response to
ethanol could underlie innate ethanol tolerance or ethanol
tolerance induced by long-term ethanol use.Indeed,the
observation that finasteride did not alter the subjective
effects of ethanol in subjects with the GABAA receptor α2
subunit polymorphism associated with alcohol depen-
dence
95 is consistent with the idea that neurosteroid
responses contribute to ethanol sensitivity and risk for
alcoholism.Both forms of tolerance may promote exces-
sive alcohol consumption.Excessive alcohol consumption,
particularly binge drinking,is a significant risk factor for
all alcohol use disorders, including alcohol dependence
and alcoholism.The restoration of ethanol sensitivity in
ethanol-dependent patients may therefore have thera-
peutic utility.However,it is unclear at this time whether
neuroactive steroid supplementation would reduce exces-
sive alcohol consumption in humans.Indeed,as mentioned
above,low doses of neuroactive steroids increased oper-
ant ethanol self-administration under some conditions,
84
while neuroactive steroids reduce ethanol consumption at
high doses
82 or in ethanol-dependent rats.
4The relationship
between HPA axis response, GABAergic neuroactive
steroids,and alcohol drinking deserves further studies in
nonhuman primates and humans.
Summary and conclusions
The effects of acute ethanol administration on neuroactive
steroid levels found in rodents have not been found in
monkeys or humans. Does this mean that neuroactive
steroids do not have an important role in ethanol action in
these species? We doubt this conclusion,since monkeys
exhibit discriminative stimulus properties of ethanol and
neuroactive steroids that are indistinguishable.
62
Furthermore,the steroid biosynthesis inhibitor finasteride
blocks the subjective effects of ethanol in humans.
95
Primates may synthesize different GABAergic neuroac-
tive steroids in response to ethanol challenge. These
steroids may include 3α,5α- and 3α,5β-reduced derivatives
of progesterone,DOC,and testosterone,all of which have
potent GABAergic activity.Further studies are needed to
translate a large body of rodent research on GABAergic
neuroactive steroids to better understand the role of
endocrine factors in alcohol sensitivity and risk for alco-
holism. ❏
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La modulación de los esteroides neuroacti-
vos por el eje hipotálamo-hipofisis-
suprarenal, influye en la sensibilidad al 
etanol y en la conducta frente a la bebida
La activación del eje hipotálamo-hipófisis-suprarre-
nal (HHS) determina una elevación de los esteroi-
des neuroactivos GABA (ácido Á-aminobutírico)-
érgicos que refuerzan la neurotransmisión de GABA
y restablecen la homeostasia después del estrés.
Esta regulación del eje HHS mantiene sana la fun-
ción cerebral y la protege frente a las enfermeda-
des neuropsiquiátricas. La sensibilidad al etanol
depende de las elevaciones de esteroides neuroac-
tivos que potencian los efectos GABAérgicos del
etanol y pueden impidiran el consumo excesivo de
alcohol por los roedores y seres humanos. La sen-
sibilidad baja al alcohol se asocia a un mayor con-
sumo de éste, con el riesgo consiguiente de eti-
lismo. De hecho, las ratas dependientes del etanol
muestran una respuesta neuroesteroidea a la admi-
nistración de etanol muy reducida, lo que puede
contribuir a la tolerancia etanólica y a la propen-
sión a beber mayores cantidades de alcohol. En esta
revisión se ofrecen pruebas que respaldan la hipó-
tesis de que los neuroesteroides contribuyen a las
acciones del etanol e impiden un consumo excesivo,
mientras que la falta de respuesta neuroesteroidea
al etanol podría explicar la tolerancia innata o cró-
nica y el mayor riesgo de excesos en la bebida. Los
neuroesteroides podrían tener una utilidad tera-
péutica en la abstinencia del alcohol o en la evita-
ción de las recaídas.
Le comportement alcoolique la sensibilité à
l’éthanol dépendent de la modulation des
stéroïdes neuroactifs GABAergiques au
niveau de l’axe hypothalamo-hypophyso-
surrénalien
L’activation de l’axe hypothalamo-hypophyso-surré-
nalien (HHS) entraine une élévation de la sécrétion
des stéroïdes neuroactifs GABA-ergiques (acide -
aminobutirique) qui stimulent la neurotransmission
GABA et restaurent l’homéostasie après le stress.
Cette régulation de l’axe HHS maintient une fonc-
tion cérébrale saine et protège des maladies neuro-
psychiatriques. Les élévations des stéroïdes neuroac-
tifs influent sur la sensibilité à l’éthanol en
augmentant ses effets GABAergiques et peuvent
ainsi prévenir les consommations alcooliques exces-
sifs chez les rongeurs et chez l’homme. Une faible
sensibilité à l’éthanol est associée à une plus grande
consommation d’alcool et à un risque d’alcoolisme
plus important. Les réponses neurostéroïdes à l’ad-
ministration d’éthanol chez des rats rendus alcoolo-
dépendants sont donc diminuées, ce qui peut contri-
buer à une tolérance à l’éthanol et à une propension
à en boire de plus grandes quantités. Cette revue de
la littérature fournit des arguments en faveur de
l’hypothèse d’une contribution des neurostéroïdes
aux effets de l’éthanol et à la prévention de sa
consommation excessive alors qu’un déficit des
réponses neurostéroïdes peut être à la base d’une
tolérance innée ou invétérée chronique et d’un
risque augmenté de consommation excessive d’al-
cool. Les neurostéroïdes peuvent avoir une utilité
thérapeutique dans le sevrage alcoolique ou dans la
prévention d’une rechute.Ethanol,HPA axis,and neuroactive steroids - Morrow et al Dialogues in Clinical Neuroscience - Vol 8 . No.4 . 2006
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